Antonetti Capital Management’s AbbVie ABBV Stock Holding History

Antonetti Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$689K	Hold	4,620	–	–	1.08%	16
2023 Q2	$622K	Buy	4,620 +100	+2%	+$14.7K	0.9%	18
2023 Q1	$720K	Buy	4,520 +211	+5%	+$32.3K	1.05%	14
2022 Q4	$696K	Sell	4,309 -155	-3%	-$23.8K	0.95%	17
2022 Q3	$599K	Sell	4,464 -200	-4%	-$28.7K	0.69%	22
2022 Q2	$714K	Buy	4,664 +30	+0.6%	+$4.58K	0.75%	22
2022 Q1	$751K	Sell	4,634 -3,261	-41%	-$474K	0.71%	22
2021 Q4	$1.07M	Sell	7,895 -271	-3%	-$32K	0.84%	20
2021 Q3	$881K	Buy	+8,166	New	+$933K	0.72%	23
2014 Q3	–	Sell	-1,350	Closed	-$76K	–	115
2014 Q2	$76K	Sell	1,350 -585	-30%	-$30.7K	0.06%	80
2014 Q1	$99K	Sell	1,935 -1,315	-40%	-$66.5K	0.09%	77
2013 Q4	$172K	Sell	3,250 -3,570	-52%	-$175K	0.16%	65
2013 Q3	$305K	Buy	6,820 +325	+5%	+$14.4K	0.31%	50
2013 Q2	$269K	Buy	+6,495	New	+$284K	0.3%	58

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Antonetti Capital Management's ABBV Position: Q3 2023 in Review

Antonetti Capital Management held its AbbVie (ABBV) position steady in Q3 2023 at 4,620 shares worth $689K. The position accounts for 1.08% of the portfolio, ranked #16.

Antonetti Capital Management first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.07M in Q4 2021. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Antonetti Capital Management held 4,620 shares of AbbVie worth $689K as of Q3 2023.
Antonetti Capital Management left its AbbVie share count unchanged in Q3 2023.
AbbVie made up 1.08% of Antonetti Capital Management's portfolio in Q3 2023, its #16 holding.
Antonetti Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
Antonetti Capital Management's AbbVie position peaked at $1.07M in Q4 2021.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.